Application of Micro- and Nano-electromechanical Devices to Drug Delivery

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2006 May 23

PMID 16715375

Citations 43

Authors

Mark Staples

Karen Daniel

Michael J Cima

Robert Langer

Affiliations

Soon will be listed here.

Abstract

Micro- and nano-electromechanical systems (MEMS and NEMS)-based drug delivery devices have become commercially-feasible due to converging technologies and regulatory accommodation. The FDA Office of Combination Products coordinates review of innovative medical therapies that join elements from multiple established categories: drugs, devices, and biologics. Combination products constructed using MEMS or NEMS technology offer revolutionary opportunities to address unmet medical needs related to dosing. These products have the potential to completely control drug release, meeting requirements for on-demand pulsatile or adjustable continuous administration for extended periods. MEMS or NEMS technologies, materials science, data management, and biological science have all significantly developed in recent years, providing a multidisciplinary foundation for developing integrated therapeutic systems. If small-scale biosensor and drug reservoir units are combined and implanted, a wireless integrated system can regulate drug release, receive sensor feedback, and transmit updates. For example, an "artificial pancreas" implementation of an integrated therapeutic system would improve diabetes management. The tools of microfabrication technology, information science, and systems biology are being combined to design increasingly sophisticated drug delivery systems that promise to significantly improve medical care.

Citing Articles

Regulatory Framework for Drug-Device Combination Products in the United States, Europe, and Korea.

Kim J, Kwon S, Seol J, Kim M, Kim S Ther Innov Regul Sci. 2024; 58(5):796-806.

PMID: 38717522 DOI: 10.1007/s43441-024-00661-2.

Enhancing the Antifouling Properties of Alumina Nanoporous Membranes by GO/MOF Impregnated Polymer Coatings: In Vitro Studies.

Moaness M, El-Sayed S, Beherei H, Mabrouk M J Funct Biomater. 2024; 15(3).

PMID: 38535243 PMC: 10970893. DOI: 10.3390/jfb15030050.

Self-powered, light-controlled, bioresorbable platforms for programmed drug delivery.

Zhang Y, Liu F, Zhang Y, Wang J, DAndrea D, Walters J Proc Natl Acad Sci U S A. 2023; 120(11):e2217734120.

PMID: 36888661 PMC: 10089205. DOI: 10.1073/pnas.2217734120.

Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges.

Hassan J, Haigh C, Ahmed T, Jasim Uddin M, Das D Pharmaceutics. 2022; 14(5).

PMID: 35631652 PMC: 9144974. DOI: 10.3390/pharmaceutics14051066.

Enhancing Clinical Translation of Cancer Using Nanoinformatics.

Soltani M, Moradi Kashkooli F, Souri M, Zare Harofte S, Harati T, Khadem A Cancers (Basel). 2021; 13(10).

PMID: 34069606 PMC: 8161319. DOI: 10.3390/cancers13102481.

References

Brunetti P, Federici M, Benedetti M . The artificial pancreas. Artif Cells Blood Substit Immobil Biotechnol. 2003; 31(2):127-38. DOI: 10.1081/bio-120020169. View

Brennan J, Gebhart S, BLACKARD W . Pump-induced insulin aggregation. A problem with the Biostator. Diabetes. 1985; 34(4):353-9. DOI: 10.2337/diab.34.4.353. View

Saghatelian A, Cravatt B . Global strategies to integrate the proteome and metabolome. Curr Opin Chem Biol. 2005; 9(1):62-8. DOI: 10.1016/j.cbpa.2004.12.004. View

McAllister D, Wang P, Davis S, Park J, Canatella P, Allen M . Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci U S A. 2003; 100(24):13755-60. PMC: 283494. DOI: 10.1073/pnas.2331316100. View

Hoane M, Puri K, Xu L, Stabila P, Zhao H, Gulwadi A . Mammalian-cell-produced neurturin (NTN) is more potent than purified Escherichia coli-produced NTN. Exp Neurol. 2000; 162(1):189-93. DOI: 10.1006/exnr.2000.7311. View

LaVan D, McGuire T, Langer R . Small-scale systems for in vivo drug delivery. Nat Biotechnol. 2003; 21(10):1184-91. DOI: 10.1038/nbt876. View

Kan S, Mokari T, Rothenberg E, Banin U . Synthesis and size-dependent properties of zinc-blende semiconductor quantum rods. Nat Mater. 2003; 2(3):155-8. DOI: 10.1038/nmat830. View

Foraker A, Walczak R, Cohen M, Boiarski T, Grove C, Swaan P . Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers. Pharm Res. 2003; 20(1):110-6. DOI: 10.1023/a:1022211127890. View

Tao S, Lubeley M, Desai T . Bioadhesive poly(methyl methacrylate) microdevices for controlled drug delivery. J Control Release. 2003; 88(2):215-28. DOI: 10.1016/s0168-3659(03)00005-1. View

10.

Hussain A, Yu X, Johnson R . Application of neural computing in pharmaceutical product development. Pharm Res. 1991; 8(10):1248-52. DOI: 10.1023/a:1015843527138. View

11.

Martin F, Walczak R, Boiarski A, Cohen M, West T, Cosentino C . Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics. J Control Release. 2005; 102(1):123-33. DOI: 10.1016/j.jconrel.2004.09.024. View

12.

Grayson A, Cima M, Langer R . Molecular release from a polymeric microreservoir device: Influence of chemistry, polymer swelling, and loading on device performance. J Biomed Mater Res A. 2004; 69(3):502-12. DOI: 10.1002/jbm.a.30019. View

13.

Ericson L, Fan H, Peng H, Davis V, Zhou W, Sulpizio J . Macroscopic, neat, single-walled carbon nanotube fibers. Science. 2004; 305(5689):1447-50. DOI: 10.1126/science.1101398. View

14.

Ahmed A, Bonner C, Desai T . Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery. J Control Release. 2002; 81(3):291-306. DOI: 10.1016/s0168-3659(02)00074-3. View

15.

Grayson A, Scheidt Shawgo R, Li Y, Cima M . Electronic MEMS for triggered delivery. Adv Drug Deliv Rev. 2004; 56(2):173-84. DOI: 10.1016/j.addr.2003.07.012. View

16.

Grayson A, Choi I, Tyler B, Wang P, Brem H, Cima M . Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater. 2003; 2(11):767-72. DOI: 10.1038/nmat998. View

17.

Maloney J, Uhland S, Polito B, Sheppard Jr N, Pelta C, Santini Jr J . Electrothermally activated microchips for implantable drug delivery and biosensing. J Control Release. 2005; 109(1-3):244-55. DOI: 10.1016/j.jconrel.2005.09.035. View

18.

Grayson A, Voskerician G, Lynn A, Anderson J, Cima M, Langer R . Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. J Biomater Sci Polym Ed. 2004; 15(10):1281-304. DOI: 10.1163/1568562041959991. View

19.

Martanto W, Davis S, Holiday N, Wang J, Gill H, Prausnitz M . Transdermal delivery of insulin using microneedles in vivo. Pharm Res. 2004; 21(6):947-52. DOI: 10.1023/b:pham.0000029282.44140.2e. View

20.

Lim F, Sun A . Microencapsulated islets as bioartificial endocrine pancreas. Science. 1980; 210(4472):908-10. DOI: 10.1126/science.6776628. View